MEDINCELL SA (MEDCL.PA) Stock Analyst Ratings
Europe - Euronext Paris - EPA:MEDCL - FR0004065605 - Common Stock
28.26 EUR
-0.42 (-1.46%)
ChartMill assigns a Buy % Consensus number of 86% to MEDCL.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.91. This target is 19.98% above the current price.
MEDCL.PA was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MEDCL.PA.
In the previous month the buy percentage consensus was at a similar level.
MEDCL.PA was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-30 | MIDCAP PARTNERS | Maintains | Buy -> Buy |
MEDINCELL SA / MEDCL.PA FAQ
What is the average price target for MEDINCELL SA (MEDCL.PA) stock?
17 analysts have analysed MEDCL.PA and the average price target is 33.91 EUR. This implies a price increase of 19.99% is expected in the next year compared to the current price of 28.26.
What is the consensus rating for MEDCL stock?
The consensus rating for MEDINCELL SA (MEDCL.PA) is 85.8824 / 100 . This indicates that analysts generally have a positive outlook on the stock.